Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,712 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,712 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,712 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,712 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,712 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,712 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,712 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
Adam C Vandervoort Chief Legal Officer, Secretary
Sold at will
$138.58K 27,083 at 5.12
20.8%
Not planned
2 Mar 2026
Thomas M Siebel Executive Chairman
Sold at will
$137.53K 17,655 at 7.79
2.3%
Not planned
2 Mar 2026
Scott B McIntosh VP, Controller, CAO
Sold at will
$136.86K 1,750 at 78.21
6.7%
Not planned
2 Mar 2026
Kelly Bliss President, U.S. Group Health
Sold at will
$136.35K 26,647 at 5.12
23.9%
Not planned
2 Mar 2026
Steven R. Bower SVP, Controller and CAO
Sold at will
$134.43K 507 at 265.15
9.7%
Not planned
2 Mar 2026
Louis H. Morrone Executive Vice President
Sold at will
$132.22K 1,144 at 115.58
1.5%
Not planned
2 Mar 2026
Michael Wittmann Chief Operating Officer
Sold on a plan 2×
$131.42K 37,500 at 3.50
23.2%
Planned (10b5-1)
2 Mar 2026
Jennifer Vecchio Group President and CMO
Sold on a plan 7×
$126.99K 419 at 303.08
0.4%
Planned (10b5-1)
2 Mar 2026
Christine Ring Chief Legal Officer
Sold on a plan
$125.79K 8,148 at 15.44
19.1%
Planned (10b5-1)
2 Mar 2026
David John Thornton MD, Americas
Sold on a plan
$123.80K 944 at 131.14
2.6%
Planned (10b5-1)
2 Mar 2026
Anil P. Ranganath See remarks
Sold at will
$120.20K 864 at 139.12
6.2%
Not planned
2 Mar 2026
Sarah Gheuens Chief Medical Officer
Sold on a plan 3×
$117.43K 4,055 at 28.96
5.7%
Planned (10b5-1)
2 Mar 2026
Paul McNab EVP, Chief Mktg & Stgy Officer
Sold at will
$116.79K 3,551 at 32.89
16.3%
Not planned
2 Mar 2026
Sold on a plan
$113.40K 10,000 at 11.34
0.5%
Planned (10b5-1)
2 Mar 2026
Gregory W Seward General Counsel
Sold at will
$110.10K 3,000 at 36.70
2.6%
Not planned
2 Mar 2026
Trevor Ogle See Remarks
Sold on a plan
$109.79K 1,689 at 65.00
19.7%
Planned (10b5-1)
2 Mar 2026
Douglas Nairne Global Chief Operating Officer
Bought
$106.74K 9,000 at 11.86
24.8%
First buy on file
2 Mar 2026
Michael Reed Webb SVP & Chief Admin Officer
Sold at will
$106.19K 954 at 111.31
10.9%
Not planned
2 Mar 2026
John E Davis Chief Commercial Officer
Sold at will
$105.86K 2,784 at 38.02
1.3%
Not planned
2 Mar 2026
Marc Wade Rosenbaum Chief Accounting Officer
Sold at will 2×
$104.81K 816 at 128.45
4.7%
Not planned
2 Mar 2026
Beth Hecht See Remarks
Sold on a plan 2×
$104.09K 16,667 at 6.25
1.3%
Planned (10b5-1)
2 Mar 2026
Carlos Nueno President, International
Sold at will
$103.18K 20,165 at 5.12
28.5%
Not planned
2 Mar 2026
Daniel Gesua Sive Salvadori EVP and Group President
Sold at will
$102.29K 885 at 115.58
0.6%
Not planned
2 Mar 2026
Janet Liang President, Oscar Insurance
Sold on a plan
$99.80K 7,453 at 13.39
2.7%
Planned (10b5-1)
2 Mar 2026
Gina Mazzariello Chief Legal Officer
Sold at will
$99.38K 6,844 at 14.52
4.8%
Not planned
2 Mar 2026
Camille L Bedrosian Chief Medical Officer
Sold at will
$94.21K 6,461 at 14.58
3.7%
Not planned
2 Mar 2026
Douglas A. Linebarger Chief Legal Officer
Sold at will
$93.25K 5,518 at 16.90
2.5%
Not planned
2 Mar 2026
Larry Todd Edwards See Remarks
Sold on a plan 2×
$92.85K 3,687 at 25.18
2.1%
Planned (10b5-1)
2 Mar 2026
Erin Hagen SVP, CHRO
Sold at will
$90.93K 2,598 at 35.00
7.9%
Not planned
2 Mar 2026
Jessica Woelfel GC, CCO, and CS
Sold on a plan
$90.89K 869 at 104.59
13.0%
Planned (10b5-1)
2 Mar 2026
Regis T. Repko SVP, System Planning&Construct
Sold on a plan
$86.85K 663 at 131.00
9.3%
Planned (10b5-1)
2 Mar 2026
Jeannette Potts Chief Legal Officer
Sold at will
$85.35K 8,578 at 9.95
7.5%
Not planned
2 Mar 2026
Fernando M. Rodrigues President of BetterHelp
Sold on a plan
$83.48K 16,314 at 5.12
39.4%
Planned (10b5-1)
2 Mar 2026
Tsveta Milanova Chief Commercial Officer
Sold on a plan 2×
$83.06K 2,868 at 28.96
6.9%
Planned (10b5-1)
2 Mar 2026
Jean F Holloway SVP, General Counsel
Sold at will
$83.01K 2,183 at 38.02
1.3%
Not planned
2 Mar 2026
Dharmendra Kumar Sinha EVP, President, Public Cloud
Sold on a plan
$82.16K 45,393 at 1.81
1.8%
Planned (10b5-1)
2 Mar 2026
Eric Shroff Senior Vice President
Sold at will
$81.95K 709 at 115.58
1.8%
Not planned
2 Mar 2026
Alec Amar President
Sold on a plan
$78.65K 27,500 at 2.86
2.0%
Planned (10b5-1)
2 Mar 2026
Mary K Moreland Executive Vice President
Sold at will
$70.85K 613 at 115.58
0.6%
Not planned
2 Mar 2026
John A. McCoy Jr. Vice President and Controller
Sold at will
$67.61K 585 at 115.58
2.3%
Not planned
2 Mar 2026
Theodore James Washburn Jr. Principal Accounting Officer
Sold on a plan 3×
$64.38K 2,223 at 28.96
46.1%
Planned (10b5-1)
2 Mar 2026
Daniel S. Lorrain Chief Scientific Officer
Sold on a plan
$62.59K 4,170 at 15.01
2.7%
Planned (10b5-1)
2 Mar 2026
Victoria Baltrus Chief Accounting Officer
Sold on a plan
$62.10K 4,638 at 13.39
2.1%
Planned (10b5-1)
2 Mar 2026
Myriam Curet EVP & Chief Medical Officer · indirect
Sold on a plan
$61.57K 125 at 492.59
2.4%
Planned (10b5-1)
2 Mar 2026
David Joseph Gaffin EVP, CLO, Alkermes, Inc.
Sold on a plan
$59.58K 2,034 at 29.29
0.8%
Planned (10b5-1)
2 Mar 2026
Effie D Silva SVP, General Counsel & Secy
Sold at will
$58.53K 1,365 at 42.88
11.7%
Not planned
2 Mar 2026
Thomas J Herzfeld Chairman of the Advisor
Bought
$57.60K 3,760 at 15.32
2.0%
Largest buy in 3 yrs
2 Mar 2026
Marshall S. Stanton SVP, Clinical & MD Affair
Sold at will
$57.53K 1,513 at 38.02
3.6%
Not planned
2 Mar 2026
Raymond Woo Chief Technology Officer
Bought on a plan
$55.24K 3,025 at 18.26
1.8%
Bought on a plan
2 Mar 2026
Andrew Callos EVP, Chief Commercial Officer
Sold on a plan
$54.60K 886 at 61.62
1.7%
Planned (10b5-1)
Showing 15,251–15,300 of 22,712. ← Newer Page 306 of 455 Older →